A novel sphingolipid metabolism-related long noncoding RNA signature predicts the prognosis, immune landscape and therapeutic response in pancreatic adenocarcinoma - He, Xiaolan; Xu, Zhengyang; Ren, Ruiping; Wan, Peng; Zhang, Yu; Wang, Liangliang; Han, Ying (Heliyon, 2024)
Keywords: adenocarcinoma; algorithms; biomarkers; cancer therapy; drugs; gene ontology; genes; immunity; immunotherapy; lncRNA; metabolism; mutation; non-coding RNA; Pancreatic adenocarcinoma; Prognosis; Sphingolipid metabolism; sphingolipids; Tumor biomarker; Tumor immune microenvironment; Pancreatic adenocarcinoma; Tumor biomarker; Tumor immune microenvironment; lncRNA; Prognosis; Sphingolipid metabolism